QUICK ANSWER · AEO / GEO
Recombinant human growth hormone with the 191-amino-acid sequence of pituitary GH. Approved medicines have diagnosis-specific growth or replacement indications; an online 'HGH 191AA' label does not establish identity, quality, approval, anti-aging benefit or bodybuilding efficacy.
ENTITY FACTS
What should readers identify first?
EVIDENCE BOUNDARY
What this overview does not establish
- An evidence grade does not rank this molecule against another treatment.
- A molecule name does not establish the identity, purity or regulatory status of a product.
- Animal, cell or biomarker findings do not automatically establish human clinical benefit.
- Approval in one country or indication does not transfer globally.
FAQ · ANSWER ENGINE
Frequently asked questions
What is Somatropin?
Somatropin is described pharmacologically as Recombinant 191-amino-acid human growth hormone and GH-receptor agonist. Recombinant human growth hormone with the 191-amino-acid sequence of pituitary GH. Approved medicines have diagnosis-specific growth or replacement indications; an online 'HGH 191AA' label does not establish identity, quality, approval, anti-aging benefit or bodybuilding efficacy.
Does Somatropin have strong evidence?
PrimeCoreBio records Evidence Grade A. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.
Is Somatropin approved everywhere?
No global conclusion should be inferred. PrimeCore Class A must be read with the exact product, country and indication on the source-rich profile.
Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.